MEGA GENOMICS 06667·

Gross margin 70.27%--56.08%14.19%58.36%2.28%72.67%14.31%47.49%25.19% Net margin 33.31%---12.09%45.40%19.85%31.94%27.43%7.58%10.93%16.50% ROE 11.38%---2.85%14.23%4.66%7.51%7.33%2.67%4.42%2.91% ROA 10.23%---2.50%12.73%3.77%6.27%6.10%2.33%3.25%2.85% Revenue growth -----38.56%--3.82%42.38%8.54%4.72%50.49%41.95% Attributable profit growth -----122.30%--270.50%392.79%49.96%220.54%-40.01%89.97% Debt-to-assets 10.06%--12.43%2.37%19.05%6.62%16.76%2.28%26.60%9.84% Current ratio 9.82--7.622.206.091.536.900.823.643.27 Operating cash flow / net profit 0.39--0.390.005.455.061.274.18-0.611.88 Operating cash flow / revenue 12.91%---4.74%17.66%108.19%112.93%34.80%73.38%-6.69%41.49%

Gross margin 73.99%--33.08%40.91% Net margin 33.54%--12.86%20.68% Revenue growth ----136.83%-- Attributable profit growth -----9.21%-- Debt-to-assets ----27.04%-- Current ratio ----3.56-- Operating cash flow / net profit ----0.68-- Operating cash flow / revenue ----8.73%--

Revenue 237.19M--145.73M38.56%151.30M3.82%164.23M8.54%247.15M50.49% Other income and gains 14.27M--19.22M34.74%11.97M37.70%6.80M43.22%7.85M15.46% Gross profit 166.68M--81.72M50.97%88.30M8.04%119.35M35.17%117.36M1.67% Selling and distribution expenses 22.98M--34.86M51.73%30.71M11.92%36.60M19.19%33.67M8.02% Administrative expenses 22.97M--42.93M86.91%22.13M48.46%22.86M3.32%27.98M22.41% Net finance costs 6.91M--719.00K89.59%1.12M56.05%1.72M53.21%1.37M20.54% Income tax 16.87M--3.80M77.47%6.14M61.61%8.59M39.85%5.81M32.39% Operating profit 102.79M---20.70M120.14%37.30M280.21%55.35M48.39%34.19M38.23% Profit before tax 95.88M---21.42M122.34%36.18M268.92%53.63M48.24%32.83M38.79% Net profit 79.02M---17.62M122.30%30.04M270.50%45.05M49.96%27.02M40.01% Net profit attributable to owners 79.02M---17.62M122.30%30.04M270.50%45.05M49.96%27.02M40.01%

Revenue 81.28M--192.50M136.83% Other income and gains 4.21M--2.56M39.12% Cost of sales 21.14M--128.82M509.34% Gross profit 60.14M--63.68M5.88% Selling and distribution expenses 10.43M--14.41M38.25% Administrative expenses 9.84M--10.76M9.37% Net finance costs 528.00K--579.00K9.66% Income tax 5.88M--6.21M5.61% Profit before tax 33.14M--30.96M6.58% Net profit 27.26M--24.75M9.21% Net profit attributable to owners 27.26M--24.75M9.21%

Cash and cash equivalents 239.10M--399.83M67.23%518.29M29.63%490.26M5.41%415.59M15.23% Trade and bills receivables 203.63M--184.82M9.24%115.88M37.30%90.06M22.28%223.32M147.97% Inventories 3.28M--3.51M6.82%4.41M25.68%4.61M4.54%39.50M756.95% Total current assets 685.36M--619.08M9.67%667.78M7.87%625.59M6.32%727.46M16.28% Total assets 772.18M--705.70M8.61%796.54M12.87%738.48M7.29%832.40M12.72% Total current liabilities 69.79M--81.25M16.41%109.71M35.03%90.64M17.38%200.03M120.69% Total liabilities 77.69M--87.70M12.89%151.72M72.99%123.80M18.40%221.46M78.89% Equity attributable to owners 694.50M--618.00M11.02%644.83M4.34%614.68M4.68%610.94M0.61% Total equity 694.50M--618.00M11.02%644.83M4.34%614.68M4.68%610.94M0.61%

Cash and cash equivalents ----424.56M-- Trade and bills receivables ----242.87M-- Inventories ----31.48M-- Total current assets ----729.80M-- Total assets ----829.96M-- Total current liabilities ----204.78M-- Total liabilities ----224.41M-- Equity attributable to owners ----605.55M-- Total equity ----605.55M--

Net cash from operating activities 30.63M---6.91M122.56%163.68M2468.46%57.15M65.08%-16.52M128.91% Net cash from investing activities -1.71M---2.56M49.47%-33.75M1217.49%6.63M119.64%-16.88M354.65% Net cash from financing activities 2.62M--158.46M5948.05%-12.91M108.15%-91.85M611.40%-41.27M55.07% Net change in cash 31.54M--148.99M372.45%117.02M21.46%-28.07M123.99%-74.67M166.03%

Net cash from operating activities ----16.80M-- Net cash from investing activities ----19.00M-- Net cash from financing activities -----27.00M--